Cell Therapies
Total Trials
3
As Lead Sponsor
2
As Collaborator
1
Total Enrollment
240
NCT04620148
TAK-242 in Patients With Acute Alcoholic Hepatitis
Phase: Phase 2
Role: Lead Sponsor
Start: Dec 31, 2021
Completion: Dec 31, 2022
NCT07010926
A Double-Blind, Randomized, Placebo-Controlled Phase II Clinical Trial to Evaluate the Safety and Efficacy of L2-01 in Subjects With Crohn's Disease
Role: Collaborator
Start: Aug 15, 2025
Completion: Dec 31, 2026
NCT04750252
Safety and Tolerability of StroMel™ in Subjects with Moderate to Severe Osteoarthritis of the Knee Joint
Phase: Phase 1/2
Start: Oct 1, 2025
Completion: Aug 31, 2027
Loading map...